Drug company Maxwellia secures GBP3.2m in investment round led by Praetura
08/04/2021 - 9:33am
A business that is poised to transform the UKs self-care market has secured a GBP3.2 million investment in a funding round led by Praetura Ventures.
Maxwellia, which is based at Alderley Park in Cheshire, aims to give people easier and faster access to the treatments they need by converting prescription-only medicines to versions that can be bought in a pharmacy.
Founded in 2013 by chief executive Anna Maxwell a pharmacist with over 20 years experience, Maxwellia specialises in switching, a process in which prescription only medication is reclassified and made available over the counter. It already has three applications under assessment with the MHRA, and is currently awaiting approval of its first game-changing womens health product following a public consultation.